SOVIPOSTOBART BETA
UNII S71HI4AAL8

Substance Identification & Data

This profile provides standardized clinical and technical data for Sovipostobart Beta, uniquely identified by the FDA Unique Ingredient Identifier (UNII) S71HI4AAL8.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2649371-20-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
S71HI4AAL8
CAS Registry Number
2649371-20-8
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
SOVIPOSTOBART BETA
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C213414
National Cancer Institute reference terminology for clinical and research data.
INN ID
13125
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Sovipostobart Beta. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

SOVIPOSTOBART BETA

Common Names & Synonyms

H-GAMMA1 HEAVY CHAIN HOMO SAPIENS (1-447) (VH (HOMO SAPIENS IGHV3-30*01 (94.9%) -(IGHD) -IGHJ4*01 (100%), CDR-IMGT (8.8.11) (26-33.51-58.97-107)) (1-118) -HOMO SAPIENS IGHG1*01V, G1M17,1>G1M3,1 CH1 R120, CH3 D12, L14 (CH1 R120 (215) (119-216), HINGE 1-15 (217-231), CH2 (232-341), CH3 D12 (357), L14 (359) (342-446), CHS K2>DEL (447)) (119-447)), (221-259')-DISULFIDE WITH L-KAPPA LIGHT CHAIN HOMO SAPIENS FUSED AT ITS N-TERMINAL END TO A CLEAVABLE PRODOMAIN (1'-259') (PRODOMAIN (1'-44') -HOMO SAPIENS V-KAPPA (HOMO SAPIENS IGKV3-20*01 (97.9%) -IGKJ1*01 (100%), CDR-IMGT (7.3.9) (71'-77'.95'-97'.134'-142')) (45'-152') -HOMO SAPIENS IGKC*01 (100%) KM3 A45.1, V101 (C-KAPPA A45.1 (198'), V101 (236')) (153'-259')); DIMER (227-227'':230-230'')-BISDISULFIDE, PRODUCED IN A CHINESE HAMSTER OVARY (CHO) CELL LINE LACKING THE ENZYME ALPHA-(1,6)-FUCOSYLTRANSFERASE (FUT8), GLYCOFORM BETA
IMMUNOGLOBULIN G1 (298-AFUCOSYLASPARAGINE,DE-C-TERMINAL-LYSINE), ANTI-(HUMAN CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED PROTEIN 4 EXTRACELLULAR DOMAIN) (HUMAN MONOCLONAL BMS-986288 .GAMMA.1-CHAIN), DISULFIDE WITH PRODOMAIN PEPTIDE (SYNTHETIC MASKING MOIETY AND PROTEASE-CLEAVABLE MOIETY) FUSION PROTEIN HUMAN MONOCLONAL BMS-986288 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS CTLA4 (CYTOTOXIC T-LYMPHOCYTE ASSOCIATED PROTEIN 4, CTLA-4, CD152)), HOMO SAPIENS MONOCLONAL ANTIBODY WITH A CLEAVABLE PRODOMAIN OF 44 AMINO ACIDS FUSED AT THE N-TERMINAL END OF THE L-KAPPA LIGHT CHAINS
SOVIPOSTOBART BETA [INN]

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus